StatPearls Publishing
All treatment decisions are based on careful evaluation of your medical history, current health status, and long-term wellness goals, with ongoing clinical oversight throughout your care
Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]
As we get more sophisticated with these gut hormone combinations, I think well be able to see more responsiveness in the population, Kumar says
But neither is the scepticism
The solution is straightforward